• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FRESENIUS KABI USA LLC IVENIX, INC.; LVP BLOOD PRODUCTS ADMINISTRATION SET, DUAL-INLET, LOW-SORBING, Y-SITE, MESH FIL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FRESENIUS KABI USA LLC IVENIX, INC.; LVP BLOOD PRODUCTS ADMINISTRATION SET, DUAL-INLET, LOW-SORBING, Y-SITE, MESH FIL Back to Search Results
Model Number SET-0014-1
Medical Device Problem Codes Leak/Splash (1354); No Apparent Adverse Event (3189)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/24/2026
Type of Reportable Event Malfunction
Event or Problem Description
The following has been reported: customer reported: "it states that the blood tubing is leaking from the secondary site.Lot number fa25a21013.A preliminary review identified the following issue: administration set leak (external part) unknown if an active infusion was stopped.Reporting as a conservative measure.No adverse effects were reported.Additional information is needed to complete the investigation.
 
Event or Problem Description
No sample or picture are available for analysis.Without the proper sample or picture evaluation is not possible to determine the probable root cause of the reported failure.The customer complaint cannot be confirmed.The most probable root cause of the reported incident is related to the lack of solvent application during the manufacturing process.The operator did not perform the joining operation correctly.Please note that without proper sample evaluation the exact root cause cannot be determined.The current process controls detection include 1) post sterilization sampling final inspection, 2) 100% visual inspection related to separated components during the manufacturing process and final physical inspections, 3) the first piece inspection will be performed to the first final assembled kit manufactured per shift.This kit will be submitted to visual inspection as per the classification of defects included in this specification and as per the applicable drawing.The batch record fa25a21013 was reviewed.No exceptions were generated that could classify as a possible root cause of this defect.The finished good lot has passed all sampling acceptance criteria for all tests performed including in-process testing and product testing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IVENIX, INC.
Common Device Name
LVP BLOOD PRODUCTS ADMINISTRATION SET, DUAL-INLET, LOW-SORBING, Y-SITE, MESH FIL
Manufacturer (Section D)
FRESENIUS KABI USA LLC
50 high street
suite 50
north andover, MA 01845
Manufacturer (Section G)
FRESENIUS KABI USA LLC
50 high street
suite 50
north andover MA 01845
Manufacturer Contact
rebecca mccandless
3 corporate drive
lake zurich, IL 60047
MDR Report Key24873162
Report Number3014732157-2026-00404
Device Sequence Number15691303
Product Code FPA
UDI-Device Identifier00811505030030
UDI-Public00811505030030
Combination Product (Y/N)N
Initial Reporter StateID
Initial Reporter CountryUS
PMA/510(K) Number
K183311
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 05/14/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Model NumberSET-0014-1
Device Catalogue NumberSET-0014-1
Device Lot NumberFA25A21013
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/24/2026
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date04/14/2026
Supplement Report FDA Received Date05/14/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured01/21/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-